HIGHLIGHTS
- who: Macrophage TGF-u03b2 signaling is et al. from the University of, Ann Arbor, Michigan, USA have published the article: Authorship note: NKP and JHN contributed equally to this work. AKH and BL contributed equally to this work. Conflict of interest: TGF- u03b2 RII-Fc was provided by Acceleron, who performed and provided results for surface plasmon resonance analysis and cell-based assays. Several authors (NKP, RK, BL, and MS) are named on a patent (US 20220211805 A1) for TGF- RII-Fc use in traumatic heterotopic ossification, in the Journal: (JOURNAL) of September/13,/2022
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.